10x Genomics, Inc. (TXG) Financials

TXG Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.0 billion 204.5 million
March 31, 2026 1.0 billion 201.4 million
Dec. 31, 2025 1.0 billion 245.0 million
Sept. 30, 2025 1.0 billion 242.2 million

TXG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 15.4 million 25.6 million
March 31, 2026 24.5 million 22.6 million
Dec. 31, 2025 39.0 million 25.2 million
Sept. 30, 2025 42.5 million 25.3 million

TXG Net Income

No data available :(

TXG Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 552.0 million - 66.8 million
March 31, 2026 539.8 million - 81.4 million
Dec. 31, 2025 523.4 million 73.4 million 73.4 million
Sept. 30, 2025 482.1 million 76.4 million 76.4 million

TXG Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 130.0 million
March 31, 2026 128.3 million
Dec. 31, 2025 127.1 million
Sept. 30, 2025 125.5 million

TXG Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.6 million 56.8 million 78.7 million -
March 31, 2026 1.6 million 56.8 million 66.4 million -
Dec. 31, 2025 1.8 million 56.0 million 76.6 million -
Sept. 30, 2025 687000 57.2 million 75.4 million -

TXG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 151.0 million 38.5 million
March 31, 2026 150.8 million 44.7 million
Dec. 31, 2025 166.0 million 53.0 million
Sept. 30, 2025 149.0 million 48.7 million

TXG Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TXG

Price: $68.59

52 week price:
11.16
68.59

Earnings Per Share: -0.59 USD

Exchange: NMS

Sector: Healthcare

Industry: Health Information Services

Country: United States

Volume: 10738

Market Capitalization: 7.9 billion

Links: